Company Ra Pharmaceuticals, Inc.
Equities
US74933V1089
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Simon Read
CTO | Chief Tech/Sci/R&D Officer | 53 | 16-04-03 |
Chief Tech/Sci/R&D Officer | 47 | 16-06-30 | |
Alonso Ricardo
CTO | Chief Tech/Sci/R&D Officer | 46 | 09-12-31 |
Investor Relations Contact | - | - | |
Corporate Officer/Principal | - | - | |
Peter DiRoma
LAW | General Counsel | - | 18-10-31 |
Kerry Black
PRN | Corporate Officer/Principal | - | 10-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Charl van Zyl
BRD | Director/Board Member | 57 | 20-04-01 |
Director/Board Member | 63 | 20-04-01 | |
Abhinav Kumar
BRD | Director/Board Member | - | 20-04-01 |
Denelle Waynick
BRD | Director/Board Member | 57 | 20-04-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,328,875 | 45,417,827 ( 95.96 %) | 0 | 95.96 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |